Latest News

STAT Plus: Beam Therapeutics raises $180 million in IPO



Beam Therapeutics (BEAM), a Cambridge, Mass., genome-editing startup, raised $180 million in an initial public offering Wednesday after increasing the number of shares it offered to investors by 48 percent.

The startup offered 10.6 million shares at $17, the high end of the expected range of $15 to $17 a share. The company originally filed to raise $100 million by offering 6.3 million shares at $15 to $17 before increasing its shares by nearly half early Wednesday.

Source link

Related posts

A bi-planar coil system for nulling background magnetic fields in scalp mounted magnetoencephalography.

Newsemia

Teen Vaping On The Rise: What Are The Risks?

Newsemia

Gut bacteria and pregnancy

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World